Arrigoni J - Search Results

1

DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans.

Mignot E, Lin X, Arrigoni J, Macaubas C, Olive F, Hallmayer J, Underhill P, Guilleminault C, Dement WC, Grumet FC. Mignot E, et al. Among authors: arrigoni j. Sleep. 1994 Dec;17(8 Suppl):S60-7. doi: 10.1093/sleep/17.suppl_8.s60. Sleep. 1994. PMID: 7701202

2

DQB1-0602 (DQw1) is not present in most nonDR2 Caucasian narcoleptics.

Mignot E, Lin X, Kalil J, George C, Singh S, Billiard M, Montplaisir J, Arrigoni J, Guilleminault C, Dement WC, et al. Mignot E, et al. Among authors: arrigoni j. Sleep. 1992 Oct;15(5):415-22. doi: 10.1093/sleep/15.5.415. Sleep. 1992. PMID: 1455124

3

Familial aspects of narcolepsy-cataplexy in the Czech Republic.

Nevsímalová S, Mignot E, Sonka K, Arrigoni JL. Nevsímalová S, et al. Among authors: arrigoni jl. Sleep. 1997 Nov;20(11):1021-6. doi: 10.1093/sleep/20.11.1021. Sleep. 1997. PMID: 9456468

4

Dopamine D2 mechanisms in canine narcolepsy.

Nishino S, Arrigoni J, Valtier D, Miller JD, Guilleminault C, Dement WC, Mignot E. Nishino S, et al. Among authors: arrigoni j. J Neurosci. 1991 Sep;11(9):2666-71. doi: 10.1523/JNEUROSCI.11-09-02666.1991. J Neurosci. 1991. PMID: 1831837 Free PMC article.

5

Canine cataplexy is preferentially controlled by adrenergic mechanisms: evidence using monoamine selective uptake inhibitors and release enhancers.

Mignot E, Renaud A, Nishino S, Arrigoni J, Guilleminault C, Dement WC. Mignot E, et al. Among authors: arrigoni j. Psychopharmacology (Berl). 1993;113(1):76-82. doi: 10.1007/BF02244337. Psychopharmacology (Berl). 1993. PMID: 7862832

6

Heterozygosity at the canarc-1 locus can confer susceptibility for narcolepsy: induction of cataplexy in heterozygous asymptomatic dogs after administration of a combination of drugs acting on monoaminergic and cholinergic systems.

Mignot E, Nishino S, Sharp LH, Arrigoni J, Siegel JM, Reid MS, Edgar DM, Ciaranello RD, Dement WC. Mignot E, et al. Among authors: arrigoni j. J Neurosci. 1993 Mar;13(3):1057-64. doi: 10.1523/JNEUROSCI.13-03-01057.1993. J Neurosci. 1993. PMID: 8095066 Free PMC article.

7

Further characterization of the alpha-1 receptor subtype involved in the control of cataplexy in canine narcolepsy.

Nishino S, Fruhstorfer B, Arrigoni J, Guilleminault C, Dement WC, Mignot E. Nishino S, et al. Among authors: arrigoni j. J Pharmacol Exp Ther. 1993 Mar;264(3):1079-84. J Pharmacol Exp Ther. 1993. PMID: 8095546

8

Desmethyl metabolites of serotonergic uptake inhibitors are more potent for suppressing canine cataplexy than their parent compounds.

Nishino S, Arrigoni J, Shelton J, Dement WC, Mignot E. Nishino S, et al. Among authors: arrigoni j. Sleep. 1993 Dec;16(8):706-12. doi: 10.1093/sleep/16.8.706. Sleep. 1993. PMID: 8165384

9

Effects of thyrotropin-releasing hormone and its analogs on daytime sleepiness and cataplexy in canine narcolepsy.

Nishino S, Arrigoni J, Shelton J, Kanbayashi T, Dement WC, Mignot E. Nishino S, et al. Among authors: arrigoni j. J Neurosci. 1997 Aug 15;17(16):6401-8. doi: 10.1523/JNEUROSCI.17-16-06401.1997. J Neurosci. 1997. PMID: 9236248 Free PMC article.

10

Validation of a cataplexy questionnaire in 983 sleep-disorders patients.

Anic-Labat S, Guilleminault C, Kraemer HC, Meehan J, Arrigoni J, Mignot E. Anic-Labat S, et al. Among authors: arrigoni j. Sleep. 1999 Feb 1;22(1):77-87. Sleep. 1999. PMID: 9989368

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters